https://old.international-pharma.com/positive-results-for-gsks-anaemia-drug-daprodustat/ 2023-10-19T22:48:56+00:00 https://old.international-pharma.com/pharma-confidence-surges-as-cphi-worldwide-2021-opens/ 2023-10-19T22:48:55+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/CPhI-1.jpeg https://old.international-pharma.com/wp-content/uploads/2021/11/CPhI-2.jpeg https://old.international-pharma.com/winners-of-the-2021-cphi-pharma-awards-have-now-been-announced/ 2023-10-19T22:48:54+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/CPhI-awards-2.jpeg https://old.international-pharma.com/acg-makes-it-better/ 2023-10-19T22:48:54+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/ACG_SIGNATURE_HOLD_TAGLINE_VERT_RED_RGB.png https://old.international-pharma.com/nice-recommends-cenobamate-for-treatment-of-adult-epilepsy-patients-in-uk/ 2023-10-19T22:48:53+00:00 https://old.international-pharma.com/vertex-receives-chmp-positive-opinion-for-kaftrio-in-children-with-cystic-fibrosis/ 2023-10-19T22:48:52+00:00 https://old.international-pharma.com/jcvi-updates-its-covid-19-booster-vaccination-guidance/ 2023-10-19T22:48:52+00:00 https://old.international-pharma.com/pfizer-signs-deal-to-allow-expanded-use-of-covid-19-treatment/ 2023-10-19T22:48:51+00:00 https://old.international-pharma.com/ec-approves-celltrions-covid-19-mab-regkirona/ 2023-10-19T22:48:50+00:00 https://old.international-pharma.com/china-sees-huge-bounce-in-pharma-rankings-ahead-of-hybrid-cphi-p-mec-china/ 2023-10-19T22:48:46+00:00 https://old.international-pharma.com/acg-capsules-launches-campaign-to-promote-problem-free-nutraceutical-production/ 2023-10-19T22:48:46+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/ACG.png https://old.international-pharma.com/global-pharma-industry-gathers-at-cphi-worldwide-2021-as-surge-in-partnering-expected-in-2022/ 2023-10-19T22:48:45+00:00 https://old.international-pharma.com/uk-recognises-covaxin-as-valid-covid-19-vaccine-for-travel/ 2023-10-19T22:48:44+00:00 https://old.international-pharma.com/nykode-therapeutics-partners-with-regeneron-to-develop-cancer-and-infectious-disease-vaccines/ 2023-10-19T22:48:44+00:00 https://old.international-pharma.com/nice-recommends-risdiplam-for-spinal-muscular-atrophy/ 2023-10-19T22:48:43+00:00 https://old.international-pharma.com/new-depression-treatment-options-from-nice/ 2023-10-19T22:48:42+00:00 https://old.international-pharma.com/behavioural-science-an-untapped-opportunity-for-medical-affairs/ 2023-10-19T22:48:41+00:00 https://old.international-pharma.com/digital-transformation-the-modern-pharmaceutical-control-tower/ 2023-10-19T22:48:41+00:00 https://old.international-pharma.com/balancing-the-complexity-efficiency-equation-in-a-fast-changing-prefilled-syringe-packaging-market/ 2023-10-19T22:48:40+00:00 https://old.international-pharma.com/the-importance-of-clinical-trial-packaging-and-the-benefits-in-outsourcing-your-small-molecule-packaging-to-a-cdmo/ 2023-10-19T22:48:36+00:00 https://old.international-pharma.com/prefillable-syringes-in-deep-cold-storage-is-this-the-way-forward-for-mass-vaccinations/ 2023-10-19T22:48:35+00:00 https://old.international-pharma.com/delivering-efficiency-on-the-packing-line/ 2023-10-19T22:48:35+00:00 https://old.international-pharma.com/ensuring-complete-product-packaging-quality/ 2023-10-19T22:48:34+00:00 https://old.international-pharma.com/product-protection-via-primary-packaging-screwcaps-to-the-rescue/ 2023-10-19T22:48:33+00:00 https://old.international-pharma.com/understanding-the-challenges-of-highly-potent-actives/ 2023-10-19T22:48:32+00:00 https://old.international-pharma.com/the-case-for-smart-real-time-quality-monitoring-in-life-sciences-manufacturing/ 2023-10-19T22:48:32+00:00 https://old.international-pharma.com/operational-readiness-the-precursor-to-operational-excellence/ 2023-10-19T22:48:31+00:00 https://old.international-pharma.com/how-technology-can-make-pharmaceutical-packaging-design-an-easier-pill-to-swallow/ 2023-10-19T22:48:30+00:00 https://old.international-pharma.com/cyber-risk-how-can-pharma-avoid-black-swan-events/ 2023-10-19T22:48:30+00:00 https://old.international-pharma.com/defining-and-regulating-the-complex-world-of-software-as-a-medical-device/ 2023-10-19T22:48:26+00:00 https://old.international-pharma.com/the-new-normal-how-covid-19-became-the-catalyst-for-change/ 2023-10-19T22:48:25+00:00 https://old.international-pharma.com/evaluation-of-an-alternative-solid-dosage-form-to-enteric-coated-pellets-containing-ibuprofen-a-case-study/ 2023-10-19T22:48:24+00:00 https://old.international-pharma.com/quality-overtakes-cost-as-the-priority-as-life-sciences-companies-move-to-automate-pharmacovigilance-case-intake/ 2023-10-19T22:48:24+00:00 https://old.international-pharma.com/the-brave-new-world-of-rapid-drug-development/ 2023-10-19T22:48:23+00:00 https://old.international-pharma.com/hyper-collaboration-in-healthcare-and-life-sciences-the-new-paradigm/ 2023-10-19T22:48:22+00:00 https://old.international-pharma.com/its-now-time-for-your-opdp-submissions-to-be-fda-compliant-are-you-ready/ 2023-10-19T22:48:22+00:00 https://old.international-pharma.com/the-new-regulatory-world-for-medical-devices/ 2023-10-19T22:48:21+00:00 https://old.international-pharma.com/how-to-coordinate-your-site-selection-with-state-economic-development/ 2023-10-19T22:48:20+00:00 https://old.international-pharma.com/preparing-for-fda-remote-inspections-what-to-expect-for-2022/ 2023-10-19T22:48:20+00:00 https://old.international-pharma.com/late-cancer-diagnoses-rise-as-nhs-struggles-with-covid-19/ 2023-10-19T22:48:15+00:00 https://old.international-pharma.com/nemera-reinforces-its-value-proposition-with-a-refreshing-visual-identity/ 2023-10-19T22:48:15+00:00 https://old.international-pharma.com/wp-content/uploads/2021/11/Nemera-logo.jpg https://old.international-pharma.com/total-uk-cases-of-omicron-rise-to-nine/ 2023-10-19T22:48:14+00:00 https://old.international-pharma.com/jcvi-responds-to-omicron-variant-and-updates-its-guidance/ 2023-10-19T22:48:13+00:00 https://old.international-pharma.com/gsk-aim-for-hiv-cure-by-2030/ 2023-10-19T22:48:13+00:00 https://old.international-pharma.com/nice-recommends-tagrisso-for-patients-with-early-stage-lung-cancer/ 2023-10-19T22:48:12+00:00 https://old.international-pharma.com/uk-study-shows-mixing-pfizer-and-astrazeneca-covid-19-vaccines-with-moderna-elicits-better-immune-response/ 2023-10-19T22:48:11+00:00 https://old.international-pharma.com/next-virus-could-be-more-lethal-than-covid-19-warns-oxford-vaccine-creator/ 2023-10-19T22:48:11+00:00 https://old.international-pharma.com/chmp-recommend-approval-for-roches-covid-19-therapy/ 2023-10-19T22:48:10+00:00 https://old.international-pharma.com/positive-phase-iii-results-for-plant-based-covid-19-vaccine/ 2023-10-19T22:48:09+00:00 https://old.international-pharma.com/roche-completed-the-repurchase-of-roche-shares-from-novartis/ 2023-10-19T22:48:05+00:00 https://old.international-pharma.com/five-drug-combination-for-ultra-high-risk-bone-marrow-cancer-identified/ 2023-10-19T22:48:04+00:00 https://old.international-pharma.com/common-diabetes-drug-not-effective-against-early-stage-breast-cancer-landmark-trial-reveals/ 2023-10-19T22:48:04+00:00 https://old.international-pharma.com/european-commission-approves-pfizers-atopic-dermatitis-treatment/ 2023-10-19T22:48:03+00:00 https://old.international-pharma.com/uk-covid-19-vaccine-pledge-faces-logistical-challenges/ 2023-10-19T22:48:02+00:00 https://old.international-pharma.com/smc-approves-first-immunotherapy-combination-for-advanced-bowel-cancer-patients-with-rare-mutation/ 2023-10-19T22:48:02+00:00 https://old.international-pharma.com/health-minister-welcomes-new-treatments-for-covid-19-patients/ 2023-10-19T22:48:01+00:00 https://old.international-pharma.com/xeris-biopharmas-glucagon-injection-becomes-available-in-uk/ 2023-10-19T22:48:00+00:00 https://old.international-pharma.com/nice-recommends-monotherapy-for-adjuvant-treatment-of-stage-3-melanoma/ 2023-10-19T22:48:00+00:00 https://old.international-pharma.com/positive-chmp-opinion-for-finerenone-as-new-treatment-for-chronic-kidney-disease-and-type-2-diabetes/ 2023-10-19T22:47:59+00:00 https://old.international-pharma.com/chmp-recommend-saphnelo-for-systematic-lupus-erythematosus/ 2023-10-19T22:47:54+00:00 https://old.international-pharma.com/cancer-researchers-across-the-uk-partner-in-new-trial-to-find-drugs-for-rare-cancers/ 2023-10-19T22:47:54+00:00 https://old.international-pharma.com/oxford-and-astrazeneca-aim-to-produce-omicron-targeted-version-of-vaccine/ 2023-10-19T22:47:53+00:00 https://old.international-pharma.com/pfizer-to-provide-uk-with-additional-2-5-treatment-courses-of-paxlovid/ 2023-10-19T22:47:53+00:00 https://old.international-pharma.com/covid-19-vaccine-should-be-offered-to-vulnerable-children-aged-five-to-11-years-old/ 2023-10-19T22:47:52+00:00 https://old.international-pharma.com/astrazeneca-and-novavax-say-their-vaccines-are-effective-against-omicron/ 2023-10-19T22:47:51+00:00 https://old.international-pharma.com/healthcare-labelling/ 2023-10-19T22:47:50+00:00 https://old.international-pharma.com/mhra-grants-approval-for-pfizers-oral-covid-19-antiviral-pill/ 2023-10-19T22:47:50+00:00 https://old.international-pharma.com/the-nice-recommends-rinvoq-for-psoriatic-arthritis-patients/ 2023-10-19T22:47:49+00:00 https://old.international-pharma.com/pregnant-women-urged-to-receive-covid-19-booster-amid-surging-cases/ 2023-10-19T22:47:48+00:00 https://old.international-pharma.com/european-commission-approves-cystic-fibrosis-treatment-for-six-to-11-year-olds/ 2023-10-19T22:47:45+00:00 https://old.international-pharma.com/oxford-joins-consortium-to-advance-quantum-drug-discovery/ 2023-10-19T22:47:44+00:00 https://old.international-pharma.com/collaborative-research-approach-set-to-accelerate-treatment-of-alport-syndrome/ 2023-10-19T22:47:43+00:00 https://old.international-pharma.com/gates-foundation-supports-hiv-and-malaria-research/ 2023-10-19T22:47:42+00:00 https://old.international-pharma.com/new-study-finds-astrazeneca-booster-generates-higher-antibodies-against-omicron/ 2023-10-19T22:47:42+00:00 https://old.international-pharma.com/poolbeg-pharma-dives-into-nasally-administered-antivirals/ 2023-10-19T22:47:41+00:00 https://old.international-pharma.com/air-of-optimism-surrounds-lung-cancer-vaccine/ 2023-10-19T22:47:40+00:00 https://old.international-pharma.com/cdi-prevention-reaches-date-with-destiny/ 2023-10-19T22:47:40+00:00 https://old.international-pharma.com/booster-vaccine-jumpstarts-omicron-protection/ 2023-10-19T22:47:39+00:00 https://old.international-pharma.com/scandi-pharma-swede-deal-for-psyros-diagnostics/ 2023-10-19T22:47:38+00:00 https://old.international-pharma.com/training-begins-for-psychedelic-assisted-clinical-trial/ 2023-10-19T22:47:34+00:00 https://old.international-pharma.com/enrol-call-verona-recruits-800-patients-for-copd-trial/ 2023-10-19T22:47:34+00:00 https://old.international-pharma.com/access-to-novartis-treatment-for-myeloid-leukaemia-patients/ 2023-10-19T22:47:33+00:00 https://old.international-pharma.com/injection-of-optimism-as-hiv-vaccine-trial-begins/ 2023-10-19T22:47:32+00:00 https://old.international-pharma.com/innovative-phase-2-trial-targets-advanced-liver-cancer/ 2023-10-19T22:47:32+00:00 https://old.international-pharma.com/gene-genies-oxford-biomedica-and-homology-medicines-create-aav-business/ 2023-10-19T22:47:31+00:00 https://old.international-pharma.com/chmp-approves-dupixent-for-young-children-with-asthma/ 2023-10-19T22:47:30+00:00 https://old.international-pharma.com/second-covid-19-antiviral-set-for-release/ 2023-10-19T22:47:29+00:00 https://old.international-pharma.com/byannli-authorised-in-britain-for-schizophrenia-treatment/ 2023-10-19T22:47:28+00:00 https://old.international-pharma.com/broadening-horizons-positive-chmp-opinion-for-expanding-ayvakyt/ 2023-10-19T22:47:27+00:00 https://old.international-pharma.com/timely-intervention-first-chronic-kidney-disease-treatment-in-20-years/ 2023-10-19T22:47:21+00:00 https://old.international-pharma.com/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity/ 2023-10-19T22:47:21+00:00 https://old.international-pharma.com/parkinsons-uk-and-domainex-join-forces-to-develop-neuroinflammation-therapies/ 2023-10-19T22:47:20+00:00 https://old.international-pharma.com/need-for-speed-kidney-cancer-patients-waiting-three-times-longer/ 2023-10-19T22:47:19+00:00 https://old.international-pharma.com/not-so-nice-cancer-patients-miss-out-on-innovative-new-treatments/ 2023-10-19T22:47:19+00:00 https://old.international-pharma.com/new-management-promising-drug-for-people-living-with-obesity/ 2023-10-19T22:47:18+00:00 https://old.international-pharma.com/asco-gu-astrazeneca-mercks-lynparza-one-ups-jjs-zejula-with-prostate-cancer-win-regardless-of-gene-mutations/ 2023-10-19T22:47:17+00:00 https://old.international-pharma.com/vertexs-trikafta-pricing-central-to-cystic-fibrosis-treatment-disparities-study-says/ 2023-10-19T22:47:17+00:00 https://old.international-pharma.com/ipsen-telegraphs-400m-deal-for-consumer-healthcare-split/ 2023-10-19T22:47:16+00:00 https://old.international-pharma.com/fda-sets-an-example-through-eli-lilly-innovents-pd-1-rocking-the-boat-for-future-contenders-analyst/ 2023-10-19T22:47:15+00:00 https://old.international-pharma.com/pfizer-and-lillys-jak-inhibitor-safety-concerns-prompt-europe-to-scrutinize-drug-class/ 2023-10-19T22:47:11+00:00 https://old.international-pharma.com/astrazeneca-pledges-more-evusheld-doses-to-us-bringing-its-antibody-supply-deal-to-855m/ 2023-10-19T22:47:10+00:00 https://old.international-pharma.com/fda-signs-off-on-lillys-new-antibody-drug-bebtelovimab-which-is-effective-against-the-omicron-variant/ 2023-10-19T22:47:10+00:00 https://old.international-pharma.com/alexion-and-uk-patient-advocacy-groups-launch-video-campaign/ 2023-10-19T22:47:09+00:00 https://old.international-pharma.com/seal-of-approval-direct-to-pcr-covid-19-test-in-the-uk-validated/ 2023-10-19T22:47:08+00:00 https://old.international-pharma.com/modernas-commercial-network-grows/ 2023-10-19T22:47:08+00:00 https://old.international-pharma.com/all-trades-syncona-announces-sale-of-portfolio-company-to-novartis/ 2023-10-19T22:47:07+00:00 https://old.international-pharma.com/nhs-gene-testing-fails-half-of-people-at-cancer-risk/ 2023-10-19T22:47:06+00:00 https://old.international-pharma.com/data-day-trial-results-deliver-hope-for-prostate-cancer-patients/ 2023-10-19T22:47:06+00:00 https://old.international-pharma.com/uk-health-leaders-call-for-urgent-mental-healthcare-plan/ 2023-10-19T22:47:05+00:00 https://old.international-pharma.com/l-b-bohle-and-korsch-announce-new-joint-facility-in-hyderabad-india/ 2023-10-19T22:47:01+00:00 https://old.international-pharma.com/wp-content/uploads/2022/02/LBB_Picture1.png https://old.international-pharma.com/find-the-right-packaging-solution-quickly-and-easily-with-the-gerresheimer-g-guide/ 2023-10-19T22:47:00+00:00 https://old.international-pharma.com/wp-content/uploads/2022/03/Gerresheimer.png https://old.international-pharma.com/neglected-rare-disease-patients-offered-hope-in-new-plan/ 2023-10-19T22:46:59+00:00 https://old.international-pharma.com/passive-or-active-supply-chain-leaders-compare-key-pharmaceutical-cold-chain-technologies-in-latest-white-paper/ 2023-10-19T22:46:59+00:00 https://old.international-pharma.com/wp-content/uploads/2022/03/TOW2022.005-White-Paper-1-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2022/03/TOW2022.005-White-Paper-2-scaled.jpg https://old.international-pharma.com/chmp-recommends-idorsias-dual-acting-treatment-quviviq-for-insomnia-patients/ 2023-10-19T22:46:58+00:00 https://old.international-pharma.com/b-medical-systems-a-global-leader-in-medical-cold-chain-solutions-has-received-the-worlds-first-pqs-prequalification-from-the-world-health-organization-who-for-its-u201-ultra-low-freezer-develope/ 2023-10-19T22:46:57+00:00 https://old.international-pharma.com/wp-content/uploads/2022/03/Bmedical-5-scaled.jpg https://old.international-pharma.com/brain-training-biomed-x-institute-collaborates-with-boehringer-ingelheim/ 2023-10-19T22:46:57+00:00 https://old.international-pharma.com/one-stop-shop-for-pharmaceutical-and-healthcare-customers/ 2023-10-19T22:46:56+00:00 https://old.international-pharma.com/wp-content/uploads/2022/03/Aenova_Sterile_Area_Detail_1-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2022/03/Aenova_Operator_starts_Optical-Control_2-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2022/03/Aenova_Kengelbach_Jan-qu_3.jpg https://old.international-pharma.com/first-treatment-for-adults-across-full-spectrum-of-chronic-heart-failure/ 2023-10-19T22:46:55+00:00 https://old.international-pharma.com/roche-launches-molecular-system-to-increase-diagnostic-testing-access/ 2023-10-19T22:46:54+00:00 https://old.international-pharma.com/gene-team-supports-therapies-for-previously-untreatable-brain-regions/ 2023-10-19T22:46:50+00:00 https://old.international-pharma.com/cell-door-ema-grants-atmp-classification-to-celtic-19/ 2023-10-19T22:46:50+00:00 https://old.international-pharma.com/new-antiviral-medicines-initiative-launched-for-future-pandemics/ 2023-10-19T22:46:49+00:00 https://old.international-pharma.com/fda-approves-first-generic-of-symbicort-to-treat-asthma-and-copd/ 2023-10-19T22:46:48+00:00 https://old.international-pharma.com/abivax-reports-promising-rheumatoid-arthritis-results/ 2023-10-19T22:46:48+00:00 https://old.international-pharma.com/state-of-the-art-rd-facilities-to-be-developed-in-oxford-city-centre/ 2023-10-19T22:46:47+00:00 https://old.international-pharma.com/bridgebio-shares-promising-data-from-muscular-dystrophy-drug-trial/ 2023-10-19T22:46:46+00:00 https://old.international-pharma.com/covid-19-infections-seeing-spike-across-uk/ 2023-10-19T22:46:46+00:00 https://old.international-pharma.com/nice-recommends-biomarins-vimizim-for-patients-with-rare-life-limiting-metabolic-disorder/ 2023-10-19T22:46:45+00:00 https://old.international-pharma.com/takedas-exkivity-receives-mhra-conditional-marketing-authorisation/ 2023-10-19T22:46:41+00:00 https://old.international-pharma.com/pfizer-to-supply-unicef-up-to-4-million-treatment-courses-of-novel-covid-19-oral-treatment-for-low-and-middle-income-countries/ 2023-10-19T22:46:40+00:00 https://old.international-pharma.com/why-pharmaceutical-manufacturers-and-airport-logistics-should-grow-hand-in-hand/ 2023-10-19T22:46:39+00:00 https://old.international-pharma.com/astrazeneca-chugai-reach-patent-dispute-settlement/ 2023-10-19T22:46:39+00:00 https://old.international-pharma.com/how-to-save-1000-kilos-of-co2-per-333-litre-refrigerated-packaging-thanks-to-the-first-ever-circular-economy-pharmaceutical-packaging/ 2023-10-19T22:46:38+00:00 https://old.international-pharma.com/getting-more-value-from-logistics-quality/ 2023-10-19T22:46:37+00:00 https://old.international-pharma.com/relevance-of-vaccine-cold-chains-around-the-world-for-the-effective-storage-and-transport-of-vaccines/ 2023-10-19T22:46:37+00:00 https://old.international-pharma.com/transport-risk-assessment-and-verification-from-theory-to-practice/ 2023-10-19T22:46:36+00:00 https://old.international-pharma.com/a-robust-product-delivers-a-reliable-solution-to-the-pharmaceutical-cold-chain/ 2023-10-19T22:46:35+00:00 https://old.international-pharma.com/purchase-or-rental-temperature-controlled-packaging-for-pharma-logistics-one-size-doesnt-fit-all/ 2023-10-19T22:46:35+00:00 https://old.international-pharma.com/automation-in-pharma-packaging-when-and-when-not-to-invest/ 2023-10-19T22:46:30+00:00 https://old.international-pharma.com/one-thing-after-another-the-pathway-towards-successful-serialisation/ 2023-10-19T22:46:30+00:00 https://old.international-pharma.com/emerging-challenges-for-data-integrity-in-the-pharmaceutical-sector/ 2023-10-19T22:46:29+00:00 https://old.international-pharma.com/the-role-of-the-clean-room-in-lal-production/ 2023-10-19T22:46:28+00:00 https://old.international-pharma.com/putting-your-atmp-process-on-the-map/ 2023-10-19T22:46:28+00:00 https://old.international-pharma.com/real-world-data-can-bridge-the-gap-between-traditional-trials-and-a-patient-centric-future/ 2023-10-19T22:46:27+00:00 https://old.international-pharma.com/improved-antibody-purification-process-through-use-of-additives/ 2023-10-19T22:46:27+00:00 https://old.international-pharma.com/evolving-clinical-trial-landscape-requires-quality-focus/ 2023-10-19T22:46:26+00:00 https://old.international-pharma.com/study-coordinators-speak-out-on-trial-site-diversity-4-ways-to-move-the-needle/ 2023-10-19T22:46:25+00:00 https://old.international-pharma.com/tackling-the-challenges-with-decentralised-trials/ 2023-10-19T22:46:25+00:00 https://old.international-pharma.com/the-enigma-of-topical-biologics-development/ 2023-10-19T22:46:21+00:00 https://old.international-pharma.com/improving-outcomes-for-gastric-cancer-patients-via-a-novel-oral-daily-dose-chemotherapy-formulation-oncoral/ 2023-10-19T22:46:20+00:00 https://old.international-pharma.com/accelerating-asias-digital-cgxp-transformation-with-industry-4-0-technologies/ 2023-10-19T22:46:19+00:00 https://old.international-pharma.com/roundtable-the-continuing-evolution-of-bioinformatics-in-the-pharma-industry/ 2023-10-19T22:46:19+00:00 https://old.international-pharma.com/reasons-why-flexibility-is-the-secret-to-pharma-success-in-2022/ 2023-10-19T22:46:18+00:00 https://old.international-pharma.com/will-universal-pharmacare-be-introduced-in-canada/ 2023-10-19T22:46:17+00:00 https://old.international-pharma.com/the-big-debate-will-quality-management-still-exist-in-2025/ 2023-10-19T22:46:17+00:00 https://old.international-pharma.com/how-managing-the-simple-medical-device-label-could-make-or-break-nordic-expansion-ambitions-for-manufacturers/ 2023-10-19T22:46:16+00:00 https://old.international-pharma.com/sanofi-wins-first-place-in-asmd-treatment-race/ 2023-10-19T22:46:15+00:00 https://old.international-pharma.com/biogen-ionis-als-drug-flops-in-trials/ 2023-10-19T22:46:15+00:00 https://old.international-pharma.com/eagle-pharmaceuticals-to-buy-acacia-pharma/ 2023-10-19T22:46:11+00:00 https://old.international-pharma.com/fda-rejects-eli-lilly-lung-cancer-med/ 2023-10-19T22:46:10+00:00 https://old.international-pharma.com/sanofi-and-igm-biosciences-team-up-to-develop-antibody-agonists/ 2023-10-19T22:46:09+00:00 https://old.international-pharma.com/stalicla-completes-phase-1b-trials-into-precision-medicine-for-autism-spectrum-disorder/ 2023-10-19T22:46:09+00:00 https://old.international-pharma.com/tower-cold-chain-launches-ktevolution-container-for-pharmaceutical-transport/ 2023-10-19T22:46:08+00:00 https://old.international-pharma.com/wp-content/uploads/2022/03/Tower_1_KTE26_1.jpg https://old.international-pharma.com/wp-content/uploads/2022/03/Tower_2_KTE57.jpg https://old.international-pharma.com/wp-content/uploads/2022/03/Tower_3_KTEvolution.jpg https://old.international-pharma.com/fda-slaps-partial-hold-on-curis-leukemia-study/ 2023-10-19T22:46:07+00:00 https://old.international-pharma.com/cphi-north-america-opens-as-65-of-us-companies-forecast-growth-in-excess-of-20-in-2022/ 2023-10-19T22:46:07+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/CPhI-North-America-Pen-Convention-Center.jpg https://old.international-pharma.com/novartis-unveils-major-re-org/ 2023-10-19T22:46:06+00:00 https://old.international-pharma.com/positive-results-for-cerevances-parkinsons-drug/ 2023-10-19T22:46:05+00:00 https://old.international-pharma.com/parsortix-system-identifies-key-drug-targets-in-cancer-metastasis/ 2023-10-19T22:46:05+00:00 https://old.international-pharma.com/mission-therapeutics-launches-clinical-trial-for-kidney-disease-therapy/ 2023-10-19T22:46:00+00:00 https://old.international-pharma.com/connectivity-sustainability-and-user-experience-to-transform-packaging-and-drug-delivery-in-next-year-pharmapack-europe-2022/ 2023-10-19T22:45:59+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/PPE-Show-Floor.jpg https://old.international-pharma.com/wp-content/uploads/2022/04/Pharmapack-1-scaled.jpg https://old.international-pharma.com/aenova-invests-in-new-building-for-the-production-of-highly-potent-drugs/ 2023-10-19T22:45:59+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/Aenova_New_Building_RGB_Sketch-scaled.jpg https://old.international-pharma.com/nice-overturns-previous-decision-recommends-merck-and-pfizers-bavencio/ 2023-10-19T22:45:58+00:00 https://old.international-pharma.com/moderna-recalls-700000-doses-of-covid-vax/ 2023-10-19T22:45:57+00:00 https://old.international-pharma.com/recipharm-completes-us-biologics-acquisitions/ 2023-10-19T22:45:57+00:00 https://old.international-pharma.com/medicare-to-provide-limited-aduhelm-coverage/ 2023-10-19T22:45:56+00:00 https://old.international-pharma.com/kings-college-london-explore-covid-19-technology-as-heart-attack-cure/ 2023-10-19T22:45:55+00:00 https://old.international-pharma.com/digital-product-protection-meets-sustainable-security-labels-made-from-paper/ 2023-10-19T22:45:55+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/Securikett-1.png https://old.international-pharma.com/wp-content/uploads/2022/04/Securikett_1.png https://old.international-pharma.com/wp-content/uploads/2022/04/Securikett_2.png https://old.international-pharma.com/imara-to-lay-off-all-but-six-employees/ 2023-10-19T22:45:50+00:00 https://old.international-pharma.com/shionogi-and-nec-collaborate-on-hepatitis-b-vaccine/ 2023-10-19T22:45:50+00:00 https://old.international-pharma.com/nice-recommends-mercks-lung-cancer-treatment/ 2023-10-19T22:45:49+00:00 https://old.international-pharma.com/aptar-pharma/ 2023-10-19T22:45:48+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/Aptar.png https://old.international-pharma.com/bms-nektar-end-cancer-partnership/ 2023-10-19T22:45:48+00:00 https://old.international-pharma.com/tower-cold-chain-wins-queens-award-for-international-trade/ 2023-10-19T22:45:47+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/Tower_Robust-Reliable-Reusable-containers-from-Tower-Cold-Chain-scaled.jpg https://old.international-pharma.com/gulf-pharmaceutical-industries-julphar-announces-its-strategy-2030-with-100-new-products-to-drive-sustainable-growth/ 2023-10-19T22:45:46+00:00 https://old.international-pharma.com/pioneering-pharma-packaging-firm-wins-queens-award-for-enterprise-in-sustainable-development/ 2023-10-19T22:45:46+00:00 https://old.international-pharma.com/wp-content/uploads/2022/04/WOOLCOOL_SOCIAL_MEDIA_PRODUCTS_600x600_PAPER_POUCH_FULL.jpg https://old.international-pharma.com/wp-content/uploads/2022/04/WOOLCOOL-HRH-4.jpg https://old.international-pharma.com/healome-therapeutics-to-accelerate-development-for-ocular-disease/ 2023-10-19T22:45:45+00:00 https://old.international-pharma.com/cancer-research-uk-reveals-innovation-engine-underpinned-by-400m-portfolio-of-cutting-edge-discovery-science/ 2023-10-19T22:45:44+00:00 https://old.international-pharma.com/vigeneron-and-daiichi-sankyo-to-develop-therapy-for-eye-diseases/ 2023-10-19T22:45:40+00:00 https://old.international-pharma.com/fda-says-not-yet-to-praxis-epilepsy-drug/ 2023-10-19T22:45:39+00:00 https://old.international-pharma.com/sgs-wins-five-categories-in-the-2022-cro-leadership-awards/ 2023-10-19T22:45:39+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/SGS-300x101-1.png https://old.international-pharma.com/idorsias-quviviq-approved-for-adults-with-chronic-insomnia-disorder/ 2023-10-19T22:45:38+00:00 https://old.international-pharma.com/bms-wins-first-fda-approval-for-hcm-drug/ 2023-10-19T22:45:38+00:00 https://old.international-pharma.com/byondis-and-medac-link-up-to-commercialise-trastuzumab-duocarmazine/ 2023-10-19T22:45:37+00:00 https://old.international-pharma.com/vertex-surprised-by-fda-hold-on-diabetes-trial/ 2023-10-19T22:45:36+00:00 https://old.international-pharma.com/equipnet-enhances-their-equipment-sustainability-programs/ 2023-10-19T22:45:35+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/equipnet-programs.jpg https://old.international-pharma.com/fda-withdraws-one-of-bms-chemo-drug-indications/ 2023-10-19T22:45:34+00:00 https://old.international-pharma.com/orion-shifts-rd-focus-to-cancer-and-pain-drugs-axes-32-employees/ 2023-10-19T22:45:34+00:00 https://old.international-pharma.com/abbvie-and-cerebras-systems-partner-to-accelerate-ai-research/ 2023-10-19T22:45:30+00:00 https://old.international-pharma.com/university-of-aberdeen-study-finds-diabetes-almost-doubles-risk-of-covid-19-death/ 2023-10-19T22:45:29+00:00 https://old.international-pharma.com/sonotec-launches-new-generation-of-its-high-accuracy-clamp-on-flow-meter-sonoflow-co-55/ 2023-10-19T22:45:28+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-v3.0-portfolio-sonotec-2_1240x800_1.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-v2.0-v3.0-portfolio-sonotec-2_1240x800_2.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-0375-v3.0-sonotec-3_1240x800_3.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-0375-v3.0-sonotec-1_1240x800_4.jpg